Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental liothyronine poisoning |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental liothyronine overdose (disorder) |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 20 microgram powder for solution for injection ampoule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely liothyronine sodium 5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 25 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 10mcg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liotrix preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing levothyroxine sodium and liothyronine sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental liothyronine poisoning |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional liothyronine poisoning |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine allergy |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine overdose |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional liothyronine overdose |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine overdose of undetermined intent |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by liothyronine |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine sodium 10mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Liothyronine allergy |
Causative agent (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 25 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 25 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 50 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
Has basis of strength substance (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet |
Has basis of strength substance (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
Has precise active ingredient |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely liothyronine sodium 5 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Liothyronine sodium 25 microgram oral tablet |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 50 microgram oral tablet |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
Has precise active ingredient |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 20 microgram powder for solution for injection ampoule |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Liothyronine sodium 20 microgram powder for solution for injection ampoule |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Liothyronine sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |